Table II.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
|
|
|||||
Characteristics | HR | 95% CI | P-value | HR | 95% CI | P-value |
Gender | ||||||
Male | Reference | Reference | ||||
Female | 0.906 | 0.467–1.758 | 0.771 | 0.945 | 0.318–2.805 | 0.919 |
Age | ||||||
Continuous | 1.001 | 0.971–1.033 | 0.928 | 0.998 | 0.922–1.080 | 0.954 |
Tumor side | ||||||
Right | Reference | Reference | ||||
Left | 0.686 | 0.379–1.241 | 0.213 | 0.475 | 0.172–1.312 | 0.151 |
BT at diagnosis | ||||||
Yes | Reference | Reference | ||||
No | 1.014 | 0.498–1.952 | 0.968 | 2.494 | 0.089–1.794 | 0.232 |
C-reactive protein (mg/ml) | ||||||
Continuous | 1.184 | 1.095–1.281 | 0.000 | 1.189 | 0.933–1.516 | 0.161 |
Hemoglobin (mg/ml) | ||||||
Continuous | 1.203 | 0.732–0.944 | 0.004 | 1.133 | 0.685–1.138 | 0.337 |
Histological type, n | ||||||
Urothelial | Reference | Reference | ||||
Non-urothelial | 2.036 | 0.924–4.486 | 0.078 | 1.951 | 0.409–9.320 | 0.402 |
Pathological grade, n | ||||||
1/2 | Reference | Reference | ||||
3 | 4.918 | 1.984–12.191 | 0.001 | 2.288 | 0.266–19.705 | 0.451 |
Adjuvant chemotherapy | ||||||
Yes | Reference | Reference | ||||
No | 1.183 | 0.333–2.144 | 0.723 | 1.499 | 0.149–2.989 | 0.597 |
Urothelial recurrence | ||||||
No | Reference | Reference | ||||
Yes | 0.929 | 0.511–1.690 | 0.809 | 0.648 | 0.215–1.956 | 0.442 |
Non-urothelial recurrence | ||||||
No | Reference | Reference | ||||
Yes | 5.750 | 3.018–10.954 | 0.000 | 9.512 | 2.293–39.464 | 0.002 |
Microvascular invasion, n | ||||||
Absent | Reference | Reference | ||||
Present | 8.299 | 3.909–17.618 | 0.000 | 3.551 | 0.585–21.558 | 0.168 |
Lymphatic invasion, n | ||||||
Absent | Reference | Reference | ||||
Present | 3.953 | 1.966–7.947 | 0.000 | 1.205 | 0.319–4.553 | 0.784 |
pT classification, n | ||||||
pT0/pTis/pTa/pT1 | Reference | Reference | ||||
pT2/pT3/pT4 | 2.619 | 1.676–4.092 | 0.000 | 0.996 | 0.275–3.611 | 0.995 |
CSS, cancer-specific survival; RNU, radical nephroureterectomy; HR, hazard ratio; UTUC, upper tract urothelial carcinoma; pT0/pTis/pTa/pT1, superficial; pT2/pT3/pT4, muscle invasive/non-organ defined.